Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 47

1.

Serum osteopontin predicts degree of hepatic fibrosis and serves as a biomarker in patients with hepatitis C virus infection.

Matsue Y, Tsutsumi M, Hayashi N, Saito T, Tsuchishima M, Toshikuni N, Arisawa T, George J.

PLoS One. 2015 Mar 11;10(3):e0118744. doi: 10.1371/journal.pone.0118744. eCollection 2015.

2.

Real-time image fusion for successful percutaneous radiofrequency ablation of hepatocellular carcinoma.

Toshikuni N, Tsutsumi M, Takuma Y, Arisawa T.

J Ultrasound Med. 2014 Nov;33(11):2005-10. doi: 10.7863/ultra.33.11.2005.

PMID:
25336489
3.

Binge alcohol consumption aggravates oxidative stress and promotes pathogenesis of NASH from obesity-induced simple steatosis.

Minato T, Tsutsumi M, Tsuchishima M, Hayashi N, Saito T, Matsue Y, Toshikuni N, Arisawa T, George J.

Mol Med. 2014 Dec 10;20:490-502. doi: 10.2119/molmed.2014.00048.

4.

Clinical differences between alcoholic liver disease and nonalcoholic fatty liver disease.

Toshikuni N, Tsutsumi M, Arisawa T.

World J Gastroenterol. 2014 Jul 14;20(26):8393-406. doi: 10.3748/wjg.v20.i26.8393. Review.

5.

Nutrition and exercise in the management of liver cirrhosis.

Toshikuni N, Arisawa T, Tsutsumi M.

World J Gastroenterol. 2014 Jun 21;20(23):7286-97. doi: 10.3748/wjg.v20.i23.7286. Review.

6.

Serum endocan as a novel prognostic biomarker in patients with hepatocellular carcinoma.

Ozaki K, Toshikuni N, George J, Minato T, Matsue Y, Arisawa T, Tsutsumi M.

J Cancer. 2014 Mar 4;5(3):221-30. doi: 10.7150/jca.7691. eCollection 2014.

7.

Hepatitis C-related liver cirrhosis - strategies for the prevention of hepatic decompensation, hepatocarcinogenesis, and mortality.

Toshikuni N, Arisawa T, Tsutsumi M.

World J Gastroenterol. 2014 Mar 21;20(11):2876-87. doi: 10.3748/wjg.v20.i11.2876. Review.

8.

The *1244 A>G polymorphism of MyD88 (rs7744) is closely associated with susceptibility to ulcerative colitis.

Matsunaga K, Tahara T, Shiroeda H, Otsuka T, Nakamura M, Shimasaki T, Toshikuni N, Kawada N, Shibata T, Arisawa T.

Mol Med Rep. 2014 Jan;9(1):28-32. doi: 10.3892/mmr.2013.1769. Epub 2013 Nov 1.

PMID:
24189845
9.

Advanced ultrasonography technologies to assess the effects of radiofrequency ablation on hepatocellular carcinoma.

Toshikuni N, Shiroeda H, Ozaki K, Matsue Y, Minato T, Nomura T, Hayashi N, Arisawa T, Tsutsumi M.

Radiol Oncol. 2013 Jul 30;47(3):224-9. doi: 10.2478/raon-2013-0033. eCollection 2013.

10.

Functional promoter polymorphisms of NFKB1 influence susceptibility to the diffuse type of gastric cancer.

Arisawa T, Tahara T, Shiroeda H, Yamada K, Nomura T, Yamada H, Hayashi R, Matsunaga K, Otsuka T, Nakamura M, Shimasaki T, Toshikuni N, Kawada N, Shibata T.

Oncol Rep. 2013 Dec;30(6):3013-9. doi: 10.3892/or.2013.2768. Epub 2013 Oct 1.

PMID:
24101096
11.

Comparison of combined transcatheter arterial chemoembolization and radiofrequency ablation with surgical resection by using propensity score matching in patients with hepatocellular carcinoma within Milan criteria.

Takuma Y, Takabatake H, Morimoto Y, Toshikuni N, Kayahara T, Makino Y, Yamamoto H.

Radiology. 2013 Dec;269(3):927-37. doi: 10.1148/radiol.13130387. Epub 2013 Oct 28.

PMID:
24086071
12.

Acetaldehyde-derived advanced glycation end-products promote alcoholic liver disease.

Hayashi N, George J, Takeuchi M, Fukumura A, Toshikuni N, Arisawa T, Tsutsumi M.

PLoS One. 2013 Jul 26;8(7):e70034. doi: 10.1371/journal.pone.0070034. Print 2013.

13.

[Radiofrequency ablation for hepatocellular carcinoma in elderly patients].

Takuma Y, Takabatake H, Morimoto Y, Toshikuni N, Yamamoto H.

Nihon Shokakibyo Gakkai Zasshi. 2013 Mar;110(3):403-11. Japanese.

PMID:
23459534
14.

Irsogladine maleate for the treatment of recurrent aphthous stomatitis in hepatitis C virus patients on pegylated-interferon and ribavirin: a pilot study.

Hayashi N, George J, Shiroeda H, Saito T, Toshikuni N, Tsuchishima M, Arisawa T, Tsutsumi M.

J Gastroenterol Hepatol. 2013 Jun;28(6):1015-8. doi: 10.1111/jgh.12137.

PMID:
23425065
15.

Comparison of the relationships of alcoholic and nonalcoholic fatty liver with hypertension, diabetes mellitus, and dyslipidemia.

Toshikuni N, Fukumura A, Hayashi N, Nomura T, Tsuchishima M, Arisawa T, Tsutsumi M.

J Clin Biochem Nutr. 2013 Jan;52(1):82-8. doi: 10.3164/jcbn.12-55. Epub 2012 Nov 13.

16.

Influence of HRH2 promoter polymorphism on aberrant DNA methylation of DAPK and CDH1 in the gastric epithelium.

Nomura T, Tahara T, Shiroeda H, Minato T, Matsue Y, Hayashi R, Matsunaga K, Otsuka T, Nakamura M, Toshikuni N, Shibata T, Arisawa T.

BMC Gastroenterol. 2013 Jan 2;13:1. doi: 10.1186/1471-230X-13-1.

17.

Needle electrode position assessed using three-dimensional ultrasonography and outcome of radiofrequency ablation in hepatocellular carcinoma.

Toshikuni N, Takuma Y, Tomokuni J, Yamamoto H.

Hepatogastroenterology. 2013 May;60(123):428-31.

PMID:
23186605
18.

Prognostic factors in hepatitis C patients with a single small hepatocellular carcinoma after radiofrequency ablation.

Toshikuni N, Takuma Y, Goto T, Yamamoto H.

Hepatogastroenterology. 2012 Nov-Dec;59(120):2361-6. doi: 10.5754/hge12934.

PMID:
23169175
19.

Measurement of spleen stiffness by acoustic radiation force impulse imaging identifies cirrhotic patients with esophageal varices.

Takuma Y, Nouso K, Morimoto Y, Tomokuni J, Sahara A, Toshikuni N, Takabatake H, Shimomura H, Doi A, Sakakibara I, Matsueda K, Yamamoto H.

Gastroenterology. 2013 Jan;144(1):92-101.e2. doi: 10.1053/j.gastro.2012.09.049. Epub 2012 Sep 27.

PMID:
23022955
20.

Association between common genetic variant of HRH2 and gastric cancer risk.

Arisawa T, Tahara T, Ozaki K, Matsue Y, Minato T, Yamada H, Nomura T, Hayashi R, Matsunaga K, Fukumura A, Nakamura M, Toshikuni N, Shiroeda H, Shibata T.

Int J Oncol. 2012 Aug;41(2):497-503. doi: 10.3892/ijo.2012.1482. Epub 2012 May 17.

PMID:
22615049
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk